STL Made Galera Therapeutics’ Stock Rises Following Positive Study for Experimental Cancer Therapy

May 11, 2021

Biopharmaceutical company Galera Therapeutics‘ stock price rose 41% after showing results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company is […]

Read More